NAFISA CHOWDHURY: Open Payments
NPI 1386354892 · PHILADELPHIA, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$597 in 24 payments from 11 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $597
Food & beverage: $597
| Company | Payments | Amount |
|---|---|---|
| Lundbeck LLC | 5 | $119 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $96 |
| Otsuka America Pharmaceutical, Inc. | 3 | $84 |
| ViiV Healthcare Company | 4 | $82 |
| Corcept Therapeutics | 2 | $58 |
| ABBVIE INC. | 2 | $50 |
| Dexcom, Inc. | 1 | $27 |
| SK Life Science, Inc. | 1 | $24 |
| Xeris Pharmaceuticals, Inc. | 1 | $23 |
| Novo Nordisk Inc | 1 | $19 |
Products named: REXULTI, CAPLYTA, DOVATO, Korlym, UBRELVY, Dexcom G6 Transmitter, RECORLEV, Ozempic.
Industry payments across PA — which companies pay providers there.
